JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nechay, B. R.
Right arrow Articles by Posey, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nechay, B. R.
Right arrow Articles by Posey, V. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 3, 599-617, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


THE PROBLEM OF Na+ + K+ ADENOSINE TRIPHOSPHATASE AS THE RECEPTOR FOR DIURETIC ACTION OF MERCURIALS AND ETHACRYNIC ACID

Bohdan R. Nechay 1, Roger F. Palmer 1, David A. Chinoy 1, and Virginia A. Posey 1

1 Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, Florida

Unless the following inconsistencies are resolved the Na+ + K+ adenosine triphosphatase (ATPase) cannot be implicated as the receptor for the diuretic action of mercurials and ethacrynic acid. 1) In vitro nondiuretic mercurials, p-chloromercuribenzoate (PCMB) and p-chloromercuriphenylsulfonate (PCMPS), are equal or more potent inhibitors than diuretic mercurials, mercaptomerin and chlormerodrin. After administration to intact dogs both PCMB and chlormerodrin (as measured by radioactivity) are bound equally to the renal membrane fraction, the site of Na+ + K+ ATPase, in concentrations capable of a substantial inhibition (<50%) in vivo. 2) In vitro the inhibitory effects of mercaptomerin and PCMB are additive, in contrast to their antagonism in vivo. 3) There is no decrease in the renal enzyme activity after an administration of mercaptomerin, PCMB or PCMPS, with a possible slight reduction after chlormerodrin. 4) In dogs pretreated with ethacrynic acid the binding of the drug (as measured by radioactivity) to the membrane fraction is 1000- to 2000-fold less than the binding required for 50% inhibition of the enzyme. The only positive correlations between the inhibition of the Na+ + K+ ATPase and the diuretic response are: 1) the inhibition by mercaptomerin (in contrast to PCMB) and mercurial diuresis are potentiated by acidosis; 2) neither the inhibition nor the diuresis is affected by pH with ethacrynic acid. Other data are presented which are more difficult to interpret. The sum of these findings challenges the small body of evidence that cardiac glycosides inhibit the renal reabsorption of Na+ by a simple inhibition of the Na+ + K+ ATPase. The summary of various diuretic combinations is: 1) noninhibitors, hydrochlorothiazide, acetazolamide, probenecid and mannitol, do not prevent the natriuretic effect of ouabain; 2) potent inhibitors, PCMB and PCMPS, neither prevent nor abolish the natriuresis induced by ouabain; 3) ouabain produces less than usual natriuresis, or loses effect, in animals pretreated with mercaptomerin, chlormerodrin or ethacrynic acid. In a few experiments mercaptomerin and ethacrynic acid do not increase the excretion of Na+ during a large natriuretic response to ouabain. This may suggest that diuretic mercurials and ethacrynic acid act either at the same receptor as ouabain or may interrupt a link within the ouabain-sensitive chain of Na+ reabsorption.

Submitted on March 3, 1967
Accepted on May 23, 1967




This article has been cited by other articles:


Home page
ScienceHome page
M. Weiner
Uncoupling agents distinguish between the effects of metabolic inhibitors and transport inhibitors
Science, April 13, 1979; 204(4389): 187 - 188.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.